Return to Article Details UNDERPRESCRIPTION OF SGLT2i IN TYPE 2 DIABETES PATIENTS WITH CARDIORENAL DISEASE IN A PUBLICLY FUNDED TERTIARY CENTER IN MALAYSIA Download Download PDF